Vaccination with dendritic cell-tumor fusion cells in multiple myeloma patients: a promising strategy?

Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma

Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer

In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer

Heat-shock proteins as dendritic cell-targeting vaccines–getting warmer

Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium

Current status and future perspectives of dendritic cell-based cancer immunotherapy

Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer

Response to HER-2 pulsed DC1 vaccines is predicted by both HER-2 and estrogen receptor expression in DCIS